PDB Short entry for 1PPF HEADER HYDROLASE/HYDROLASE INHIBITOR 24-OCT-91 1PPF TITLE X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE TITLE 2 (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR CAVEAT 1PPF GLN E 243 HAS WRONG CHIRALITY AT ATOM CA NAG B 5 HAS WRONG CAVEAT 2 1PPF CHIRALITY AT ATOM C3 NAG B 5 HAS WRONG CHIRALITY AT ATOM C5 CAVEAT 3 1PPF GLC B 6 HAS WRONG CHIRALITY AT ATOM C3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN LEUKOCYTE ELASTASE; COMPND 3 CHAIN: E; COMPND 4 EC: 3.4.21.37; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: TURKEY OVOMUCOID INHIBITOR (OMTKY3); COMPND 8 CHAIN: I; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: MELEAGRIS GALLOPAVO; SOURCE 7 ORGANISM_COMMON: TURKEY; SOURCE 8 ORGANISM_TAXID: 9103 KEYWDS SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.BODE,A-Z.WEI REVDAT 5 29-JUL-20 1PPF 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1PPF 1 VERSN REVDAT 3 25-AUG-09 1PPF 1 SOURCE REVDAT 2 24-FEB-09 1PPF 1 VERSN REVDAT 1 31-JAN-94 1PPF 0 JRNL AUTH W.BODE,A.Z.WEI,R.HUBER,E.MEYER,J.TRAVIS,S.NEUMANN JRNL TITL X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE JRNL TITL 2 ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY JRNL TITL 3 OVOMUCOID INHIBITOR. JRNL REF EMBO J. V. 5 2453 1986 JRNL REFN ISSN 0261-4189 JRNL PMID 3640709 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.BODE,A.Z.WEI,M.STUBBS,M.LASKOWSKI REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH W.BODE,E.MEYER,J.C.POWERS REMARK 1 TITL HUMAN LEUKOCYTE AND PORCINE PANCREATIC ELASTASE: X-RAY REMARK 1 TITL 2 CRYSTAL STRUCTURE, MECHANISM, SUBSTRATE SPECIFICITY, AND REMARK 1 TITL 3 MECHANISM-BASED INHIBITORS REMARK 1 REF BIOCHEMISTRY V. 28 1951 1989 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.Z.WEI,I.MAYR,W.BODE REMARK 1 TITL THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN REMARK 1 TITL 2 LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL REMARK 1 TITL 3 KETONE INHIBITOR REMARK 1 REF FEBS LETT. V. 234 367 1988 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 4 REMARK 1 AUTH S.SINHA,W.WATOREK,S.KARR,J.GILES,W.BODE,J.TRAVIS REMARK 1 TITL PRIMARY STRUCTURE OF HUMAN NEUTROPHIL ELASTASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 84 2228 1987 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : EREF REMARK 3 AUTHORS : JACK,LEVITT REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2054 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 192 REMARK 3 SOLVENT ATOMS : 272 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE SER 195 OG - LEU 18I C INTERACTION HAS NOT BEEN REMARK 3 CONSTRAINED ("FREE APPROACH"). REMARK 3 REMARK 3 HLE: 218 RESIDUES FROM ILE E 16 TO GLN E 243 ARE DEFINED BY REMARK 3 ELECTRON DENSITY; THERE MIGHT BE ONE OR MORE ADDITIONAL REMARK 3 RESIDUES PRESENT AT THE C-TERMINUS (WHERE REMARK 3 POSTTRANSLATIONAL TRIMMING OCCURS). REMARK 4 REMARK 4 1PPF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175785. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.52500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 26.22500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.27500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 26.22500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.52500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.27500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG E 23 NH1 NH2 REMARK 480 VAL E 63A CG1 CG2 REMARK 480 ARG E 76 CD NE CZ NH1 NH2 REMARK 480 ARG E 129 CD NE CZ NH1 NH2 REMARK 480 ARG E 178 NE CZ NH1 NH2 REMARK 480 LEU E 223 CD1 CD2 REMARK 480 ASN I 45 CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS I 29 O2 MAN B 7 3645 1.16 REMARK 500 CG ARG E 21 O HOH E 956 4565 1.20 REMARK 500 CB ARG E 21 O HOH E 956 4565 1.33 REMARK 500 CG GLN E 187 O HOH E 883 3645 1.35 REMARK 500 N ASN I 45 O2 GLC B 6 3645 1.41 REMARK 500 C SER I 44 O2 GLC B 6 3645 1.47 REMARK 500 O7 NAG B 5 O HOH I 894 3655 1.66 REMARK 500 O SER I 44 O2 GLC B 6 3645 1.71 REMARK 500 CA ASN I 45 O2 GLC B 6 3645 1.71 REMARK 500 O6 GLC B 6 O HOH E 1165 3654 1.78 REMARK 500 CG2 VAL E 97 C6 NAG A 5 4465 1.82 REMARK 500 O HOH E 988 O HOH I 634 3645 2.02 REMARK 500 CD GLN E 187 O HOH E 883 3645 2.03 REMARK 500 O HOH E 937 O HOH I 767 2574 2.04 REMARK 500 CB SER I 44 O3 NAG B 5 3645 2.04 REMARK 500 CD ARG E 87 O HOH I 1017 2574 2.05 REMARK 500 O HOH E 620 O HOH I 1142 3645 2.05 REMARK 500 N ASN I 45 C2 GLC B 6 3645 2.07 REMARK 500 CA SER I 44 O3 NAG B 5 3645 2.08 REMARK 500 NH2 ARG E 63B O HOH E 907 2575 2.09 REMARK 500 OE1 GLN E 187 O HOH E 883 3645 2.11 REMARK 500 CD ARG E 21 O HOH E 956 4565 2.16 REMARK 500 O HOH E 561 O HOH E 901 2575 2.18 REMARK 500 O HOH E 1090 O HOH I 1019 2574 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG E 20 CZ ARG E 20 NH2 0.083 REMARK 500 TRP E 27 NE1 TRP E 27 CE2 -0.105 REMARK 500 HIS E 57 CE1 HIS E 57 NE2 0.128 REMARK 500 ARG E 87 NE ARG E 87 CZ 0.080 REMARK 500 TRP E 141 NE1 TRP E 141 CE2 -0.089 REMARK 500 ARG E 146 CZ ARG E 146 NH1 0.083 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG E 20 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG E 36 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG E 65 CA - CB - CG ANGL. DEV. = -14.3 DEGREES REMARK 500 ARG E 65 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG E 65 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 LEU E 68 CB - CG - CD2 ANGL. DEV. = 10.4 DEGREES REMARK 500 ARG E 75 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 GLU E 90 N - CA - CB ANGL. DEV. = -11.3 DEGREES REMARK 500 ASP E 95 CB - CG - OD1 ANGL. DEV. = 7.5 DEGREES REMARK 500 VAL E 120 CA - CB - CG1 ANGL. DEV. = 9.3 DEGREES REMARK 500 ARG E 128 NE - CZ - NH1 ANGL. DEV. = 7.4 DEGREES REMARK 500 ARG E 128 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG E 146 CD - NE - CZ ANGL. DEV. = 10.2 DEGREES REMARK 500 ARG E 146 NE - CZ - NH1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG E 146 NE - CZ - NH2 ANGL. DEV. = -7.2 DEGREES REMARK 500 VAL E 163 CA - CB - CG2 ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG E 186 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG E 186B NE - CZ - NH1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ARG E 186B NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 CYS E 201 CA - CB - SG ANGL. DEV. = 12.3 DEGREES REMARK 500 ARG E 217 CD - NE - CZ ANGL. DEV. = 17.1 DEGREES REMARK 500 ARG E 217 NE - CZ - NH1 ANGL. DEV. = 10.6 DEGREES REMARK 500 ARG E 217 NE - CZ - NH2 ANGL. DEV. = -8.4 DEGREES REMARK 500 TYR E 224 CB - CG - CD2 ANGL. DEV. = -4.4 DEGREES REMARK 500 GLN E 243 N - CA - CB ANGL. DEV. = 17.8 DEGREES REMARK 500 SER I 5 CB - CA - C ANGL. DEV. = -12.7 DEGREES REMARK 500 ARG I 21 NE - CZ - NH1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG I 21 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ASN I 28 CB - CA - C ANGL. DEV. = -12.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN E 61 19.87 59.27 REMARK 500 HIS E 71 -55.63 -134.52 REMARK 500 ASN E 92 63.69 -153.99 REMARK 500 SER E 214 -60.05 -120.01 REMARK 500 ALA I 3 46.87 34.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 CYS E 58 10.17 REMARK 500 VAL E 64 12.28 REMARK 500 GLY E 93 -11.36 REMARK 500 ASN E 132 12.89 REMARK 500 LEU E 137 -12.77 REMARK 500 ARG E 146 13.96 REMARK 500 VAL E 185 13.33 REMARK 500 ARG E 217 10.13 REMARK 500 CYS E 220 -12.89 REMARK 500 TYR E 224 12.09 REMARK 500 PHE E 228 -12.20 REMARK 500 SER E 240 -16.72 REMARK 500 SER I 5 -19.79 REMARK 500 ALA I 15 -12.98 REMARK 500 PHE I 53 10.30 REMARK 500 LYS I 55 -12.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ASN 109 AND ASN 159 ARE GLYCOSYLATED; AT BOTH SITES AN REMARK 600 ASN-LINKED N-ACETYLGLUCOSAMINE, AN ALPHA-1, 6-BOUND REMARK 600 L-FUCOPYRANOSE AND A BETA-1, 4-LINKED N-ACETYLGLUCOSAMINE REMARK 600 ARE WELL DEFINED, A BRANCHING MANNOSE SUGAR IN PART. REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 MAN A 4 REMARK 615 NAG A 5 REMARK 615 GAL A 6 REMARK 615 MAN A 7 REMARK 615 MAN B 4 REMARK 615 NAG B 5 REMARK 615 GLC B 6 REMARK 615 MAN B 7 REMARK 615 BMA A 3 REMARK 615 BMA B 3 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEETS PRESENTED AS *B1* AND *B2* ON SHEET RECORDS REMARK 700 BELOW ARE ACTUALLY SIX-STRANDED BETA-BARRELS. THESE ARE REMARK 700 REPRESENTED BY SEVEN-STRANDED SHEETS IN WHICH THE FIRST AND REMARK 700 LAST STRANDS ARE IDENTICAL. DBREF 1PPF E 16 243 UNP P08246 ELNE_HUMAN 30 247 DBREF 1PPF I 1 56 UNP P01004 IOVO_MELGA 130 185 SEQRES 1 E 218 ILE VAL GLY GLY ARG ARG ALA ARG PRO HIS ALA TRP PRO SEQRES 2 E 218 PHE MET VAL SER LEU GLN LEU ARG GLY GLY HIS PHE CYS SEQRES 3 E 218 GLY ALA THR LEU ILE ALA PRO ASN PHE VAL MET SER ALA SEQRES 4 E 218 ALA HIS CYS VAL ALA ASN VAL ASN VAL ARG ALA VAL ARG SEQRES 5 E 218 VAL VAL LEU GLY ALA HIS ASN LEU SER ARG ARG GLU PRO SEQRES 6 E 218 THR ARG GLN VAL PHE ALA VAL GLN ARG ILE PHE GLU ASN SEQRES 7 E 218 GLY TYR ASP PRO VAL ASN LEU LEU ASN ASP ILE VAL ILE SEQRES 8 E 218 LEU GLN LEU ASN GLY SER ALA THR ILE ASN ALA ASN VAL SEQRES 9 E 218 GLN VAL ALA GLN LEU PRO ALA GLN GLY ARG ARG LEU GLY SEQRES 10 E 218 ASN GLY VAL GLN CYS LEU ALA MET GLY TRP GLY LEU LEU SEQRES 11 E 218 GLY ARG ASN ARG GLY ILE ALA SER VAL LEU GLN GLU LEU SEQRES 12 E 218 ASN VAL THR VAL VAL THR SER LEU CYS ARG ARG SER ASN SEQRES 13 E 218 VAL CYS THR LEU VAL ARG GLY ARG GLN ALA GLY VAL CYS SEQRES 14 E 218 PHE GLY ASP SER GLY SER PRO LEU VAL CYS ASN GLY LEU SEQRES 15 E 218 ILE HIS GLY ILE ALA SER PHE VAL ARG GLY GLY CYS ALA SEQRES 16 E 218 SER GLY LEU TYR PRO ASP ALA PHE ALA PRO VAL ALA GLN SEQRES 17 E 218 PHE VAL ASN TRP ILE ASP SER ILE ILE GLN SEQRES 1 I 56 LEU ALA ALA VAL SER VAL ASP CYS SER GLU TYR PRO LYS SEQRES 2 I 56 PRO ALA CYS THR LEU GLU TYR ARG PRO LEU CYS GLY SER SEQRES 3 I 56 ASP ASN LYS THR TYR GLY ASN LYS CYS ASN PHE CYS ASN SEQRES 4 I 56 ALA VAL VAL GLU SER ASN GLY THR LEU THR LEU SER HIS SEQRES 5 I 56 PHE GLY LYS CYS MODRES 1PPF ASN E 109 ASN GLYCOSYLATION SITE MODRES 1PPF ASN E 159 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET BMA A 3 11 HET MAN A 4 11 HET NAG A 5 14 HET GAL A 6 11 HET MAN A 7 11 HET FUC A 8 10 HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET NAG B 5 14 HET GLC B 6 11 HET MAN B 7 11 HET FUC B 8 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM GLC ALPHA-D-GLUCOPYRANOSE FORMUL 3 NAG 6(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 4(C6 H12 O6) FORMUL 3 GAL C6 H12 O6 FORMUL 3 FUC 2(C6 H12 O5) FORMUL 4 GLC C6 H12 O6 FORMUL 5 HOH *272(H2 O) HELIX 1 1 ALA E 55 ALA E 60 5 6 HELIX 2 2 ASN E 63 VAL E 64 5 5 HELIX 3 3 PRO E 230 GLN E 243 5MIXED 3/10 + 3.6/13 14 SHEET 1 B1 7 PRO E 28 ARG E 36 0 SHEET 2 B1 7 GLY E 38 PRO E 49 -1 SHEET 3 B1 7 ASN E 50 SER E 54 -1 SHEET 4 B1 7 ASN E 98 ASN E 109 -1 SHEET 5 B1 7 SER E 74 VAL E 97 -1 SHEET 6 B1 7 VAL E 66 LEU E 73 -1 SHEET 7 B1 7 PRO E 28 ARG E 36 -1 SHEET 1 B2 7 GLY E 133 ARG E 146 0 SHEET 2 B2 7 ASN E 147 VAL E 163 -1 SHEET 3 B2 7 VAL E 181 LEU E 184 -1 SHEET 4 B2 7 ASP E 226 ALA E 229 -1 SHEET 5 B2 7 GLY E 207 PHE E 215 -1 SHEET 6 B2 7 SER E 197 ASN E 202 -1 SHEET 7 B2 7 GLY E 133 ARG E 146 -1 SSBOND 1 CYS E 42 CYS E 58 1555 1555 2.00 SSBOND 2 CYS E 136 CYS E 201 1555 1555 2.02 SSBOND 3 CYS E 168 CYS E 182 1555 1555 1.97 SSBOND 4 CYS E 191 CYS E 220 1555 1555 2.02 SSBOND 5 CYS I 8 CYS I 38 1555 1555 2.04 SSBOND 6 CYS I 16 CYS I 35 1555 1555 2.07 SSBOND 7 CYS I 24 CYS I 56 1555 1555 2.06 LINK ND2 ASN E 109 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN E 159 C1 NAG A 1 1555 1555 1.44 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.44 LINK O6 NAG A 1 C1 FUC A 8 1555 1555 1.42 LINK O4 NAG A 2 C1 BMA A 3 1555 1555 1.47 LINK O6 BMA A 3 C1 MAN A 4 1555 1555 1.43 LINK O3 BMA A 3 C1 MAN A 7 1555 1555 1.44 LINK O2 MAN A 4 C1 NAG A 5 1555 1555 1.43 LINK O4 NAG A 5 C1 GAL A 6 1555 1555 1.43 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O6 NAG B 1 C1 FUC B 8 1555 1555 1.43 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.46 LINK O6 BMA B 3 C1 MAN B 4 1555 1555 1.43 LINK O3 BMA B 3 C1 MAN B 7 1555 1555 1.43 LINK O2 MAN B 4 C1 NAG B 5 1555 1555 1.43 LINK O4 NAG B 5 C1 GLC B 6 1555 1555 1.43 CISPEP 1 TYR I 11 PRO I 12 0 12.47 CRYST1 73.050 72.550 52.450 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013689 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013784 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019066 0.00000